coadministered cagrilintide and semaglutide in adults with overweight or obesity the REDEFINE 2 phase 3a trial We are all anxiously awaiting

Oct 2024;22(10):565-574

Tell your provider if you are pregnant/breastfeeding, have a history of cancer, autoimmune disease, or take prescription medications (especially immunosuppressants or anticoagulants), and report any persistent or severe symptoms right away

BPC-157 5mg/10mg Research Peptide Body Protection Compound 98% Purity COA Verified For research and laboratory use only

It is not a first-line agent for acute trauma, and it should not be used in the context of active infection, malignancy or unstable medical conditions

All lots meet 99% purity specifications

They are not approved as a pharmaceutical or dietary supplement